samedan logo
 
 
spacer
home > ict > summer 2007 > image conscious
PUBLICATIONS
International Clinical Trials

Image Conscious

In adopting a medical imaging strategy, Gunter Bellaire of Perceptive Informatics assesses the potential variability of imaging data collected in multicentre trials, and the variability introduced when interpreting that data

Imaging modalities such as computer tomography (CT) and magnetic resonance imaging (MRI) can provide insight into drug efficacy and safety in a non-invasive way that often provides a faster way to reach traditional clinical endpoints (1).

In the past, even for pivotal studies, only site assessments of imaging data (local image review) were taken into account for study result analysis. However, in recent years, the value of a centralised imaging review has been acknowledged and continues to grow in popularity, making it now the method of choice, particularly for pivotal studies (2). In particular, the standardisation of image acquisition, and independence from clinical patient information, supports the objectivity of image analysis.

The independent centralised review (ICR) process aims for the reproducible outcome of expert image review (3,4). There are ways to assess reproducibility, such as comparing the variability among multiple expert reviewers, or looking at the variability of a single reviewer over time. The features of the central review that contribute to reproducibility are: standardised image acquisition; site and reviewer training; and tools to support the review process. This articles focuses on these aspects and discusses the potential effects attributed to each one.

STANDARDISED IMAGE ACQUISITION

Imaging modalities nowadays are highly complicated devices with various degrees of functioning/flexibility. The overall imaging modalities of choice are usually defined in the study protocol. In a multicentre clinical trial, the local imaging standards and the variety of available modality generations and individual software packages (5), which are defined for local usage, require a considered decision to provide guidance for image acquisition that meets the needs of such a trial.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Gunter Bellaire, PhD, is the Director of Operations at Perceptive Informatics (a PAREXEL International Company), based in the Berlin office for worldwide medical imaging operations. Before taking his post as Director of Operations, Gunter led the EU Perceptive Operations for medical imaging, interactive voice response systems and web solutions. Prior to joining Perceptive in June 2002, he was CTO at MedliveTV. Gunter has also worked as a Senior IT Manager for companies dealing with electronic patient records, medical portals, integrated hospital, and GP information systems.
spacer
Gunter Bellaire, PhD
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

PAT and Quality by Design for Biopharmaceuticals

25-26 May 2010, London, UK

Pharma IQ is delighted to announce the inaugural PAT and quality by design for biopharmaceuticals, being held in London on the 25th-26th May 2010. With PAT and quality by design techniques now established within the small molecules field the focus is shifting to application within the biopharmaceuticals arena, with key regulatory bodies such as the FDA and EMEA actively getting involved I pilot case studies. This event will bring together professionals specifically tasked with implementing PAT and QbD tools and techniques specifically within the bioprocess and bioproduction area.
More info >>

 
News and Press Releases

Catalent Plant Achieves ISO 15378 Certification

Catalent Pharma Solutions, one of the leading providers of advanced technologies and outsourced services to the global pharmaceutical, biotechnology and consumer health industry, announces the recent achievement of ISO 15378 certification of its Printed Components facility in Dublin, Ireland. Catalent is the first secondary packaging company in Ireland to achieve the ISO 15378 certification standard.
More info >>

 

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement